2012
DOI: 10.1186/1897-4287-10-s2-a59
|View full text |Cite
|
Sign up to set email alerts
|

RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…There are a number of interactions linking RAD21 to BRCA2, the most strongly associated prostate cancer pre-disposition gene [47]. RAD21 over-expression is commonly observed in BRCA2 present prostate cancer [55], where RAD21 is a key component of a cohesion complex needed for several cellular processes. In fact, RAD21 over-expression was present in 53% of the prostate tumours and is perhaps an equivalently useful biomarker in prostate cancer as BRCA2.…”
Section: Resultsmentioning
confidence: 99%
“…There are a number of interactions linking RAD21 to BRCA2, the most strongly associated prostate cancer pre-disposition gene [47]. RAD21 over-expression is commonly observed in BRCA2 present prostate cancer [55], where RAD21 is a key component of a cohesion complex needed for several cellular processes. In fact, RAD21 over-expression was present in 53% of the prostate tumours and is perhaps an equivalently useful biomarker in prostate cancer as BRCA2.…”
Section: Resultsmentioning
confidence: 99%
“…Mutated RAD21 has been detected in 2.48% of all cancers and represents adenocarcinomas of the breast, lung, colon, and prostate [ 14 ]. Furthermore, RAD21 overexpression is associated with more aggressive PCa and is frequently observed in BRCA-mutated prostatic tumors [ 29 ]. In addition, RAD21 is commonly amplified in advanced androgen-resistant PCa [ 30 ], suggesting alternative genetic mechanisms in our patient.…”
Section: Discussionmentioning
confidence: 99%